Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17beta-estradiol: a preliminary study
- PMID: 11411813
- DOI: 10.4088/jcp.v62n0504
Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17beta-estradiol: a preliminary study
Abstract
Background: The postpartum period is a time when women are vulnerable to depressive disorders, which can be severe and have long-lasting adverse sequelae. In spite of multiple contacts with health care providers, women with postpartum depression often remain unrecognized and untreated. To evaluate the association between estradiol and postpartum depression, we measured serum estradiol concentration and performed an open-label study of physiologic 17beta-estradiol.
Method: Twenty-three women fulfilling ICD-10 criteria for major depression with postpartum onset were consecutively recruited from a psychiatric emergency unit. Serum estradiol concentrations were measured at baseline and weekly during sublingual 17beta-estradiol treatment for 8 weeks. The treatment effect was assessed using a clinician-rated depression symptom scale, the Montgomery-Asberg Depression Rating Scale (MADRS).
Results: At baseline, all patients were severely depressed (mean MADRS total score = 40.7; range, 35-45) and had a low serum estradiol concentration (mean = 79.8 pmol/L; range, 23-140 pmol/L); in 16/23 patients, the concentration was even lower than the threshold value for gonadal failure. During the first week of estradiol treatment, depressive symptoms diminished significantly, resulting in a mean MADRS score of 11.0 (Z = -4.20, p < .001), and serum estradiol concentrations approached those of the follicular phase (mean +/- SD = 342 +/- 141 pmol/L). At the end of the second week of treatment, the MADRS scores were compatible with clinical recovery in 19/23 patients.
Conclusion: This preliminary study shows that depression symptoms may be rapidly reduced in patients with postpartum depression who have documented estradiol deficiency by treatment with 17beta-estradiol and suggests that estradiol can have significance in the pathophysiology of this condition and may be an option in the treatment of women vulnerable to postpartum depression.
Comment in
-
Efficacy of 17beta-estradiol on depression: is estrogen deficiency really necessary?J Clin Psychiatry. 2002 May;63(5):451; author reply 451-2. doi: 10.4088/jcp.v63n0513a. J Clin Psychiatry. 2002. PMID: 12019671 No abstract available.
Similar articles
-
Positive treatment effect of estradiol in postpartum psychosis: a pilot study.J Clin Psychiatry. 2000 Mar;61(3):166-9. doi: 10.4088/jcp.v61n0303. J Clin Psychiatry. 2000. PMID: 10817099 Clinical Trial.
-
Role of estradiol in puerperal psychosis.Psychopharmacology (Berl). 1999 Nov;147(1):108-10. doi: 10.1007/s002130051149. Psychopharmacology (Berl). 1999. PMID: 10591876
-
Effect of oestradiol on postpartum depression.Psychopharmacology (Berl). 1999 Sep 1;146(1):108-10. doi: 10.1007/s002130051095. Psychopharmacology (Berl). 1999. PMID: 10485972
-
Novel Augmentation Strategies in Major Depression.Dan Med J. 2017 Apr;64(4):B5338. Dan Med J. 2017. PMID: 28385173 Review.
-
Transdermal estradiol for postpartum depression: a promising treatment option.Clin Obstet Gynecol. 2009 Sep;52(3):516-29. doi: 10.1097/GRF.0b013e3181b5a395. Clin Obstet Gynecol. 2009. PMID: 19661765 Free PMC article. Review.
Cited by
-
Antidepressant effects of activation of infralimbic cortex via upregulation of BDNF and β-catenin in an estradiol withdrawal model.Psychopharmacology (Berl). 2024 May 14. doi: 10.1007/s00213-024-06610-z. Online ahead of print. Psychopharmacology (Berl). 2024. PMID: 38743109
-
Prolonged HPA axis dysregulation in postpartum depression associated with adverse early life experiences: A cross-species translational study.Nat Ment Health. 2024 May;2(5):593-604. doi: 10.1038/s44220-024-00217-1. Epub 2024 Apr 11. Nat Ment Health. 2024. PMID: 38736646 Free PMC article.
-
Effectiveness of interpersonal psychotherapy in comparison to other psychological and pharmacological interventions for reducing depressive symptoms in women diagnosed with postpartum depression in low- and middle-income countries: A systematic review.Campbell Syst Rev. 2024 Apr 21;20(2):e1399. doi: 10.1002/cl2.1399. eCollection 2024 Jun. Campbell Syst Rev. 2024. PMID: 38645302 Free PMC article. Review.
-
Higher number of steps is related to lower endogenous progesterone but not estradiol levels in women.PLoS One. 2024 Apr 4;19(4):e0299580. doi: 10.1371/journal.pone.0299580. eCollection 2024. PLoS One. 2024. PMID: 38573970 Free PMC article.
-
Depression in Women: Potential Biological and Sociocultural Factors Driving the Sex Effect.Neuropsychobiology. 2024;83(1):2-16. doi: 10.1159/000531588. Epub 2024 Jan 25. Neuropsychobiology. 2024. PMID: 38272005 Free PMC article. Review.